Clinical Trials Browser

Exanthema

NCT07426822 2026-02-24

SAFE-CAP

Phase 2 Not yet recruiting

108 enrolled

Diarrhea, Exanthema

NCT06399029 2025-11-19

TRUX-LST

Phase 2 Recruiting

20 enrolled

Exanthema

NCT03992664 2025-02-13

Education Intervention in Patients with Rash Due to Epidermal Growth Factor Receptor (EGFR) Treatment.

Phase NA Completed

40 enrolled

BreastGastrointestinalHead & NeckThoracic

Breast Neoplasms, Colonic Neoplasms, Exanthema, Head and Neck Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Photosensitivity Disorders, Pruritus

NCT05966584 2024-08-29

A Study to Prevent Rash in People Starting Alpelisib for the Treatment of Breast Cancer

Phase 2 Terminated

1 enrolled 5 charts

Breast

Breast Neoplasms, Exanthema

NCT04878692 2021-05-07

OPERA

Phase NA Unknown

96 enrolled

GastrointestinalHead & NeckThoracic

Acne Vulgaris, Carcinoma, Non-Small-Cell Lung, Exanthema, Head and Neck Neoplasms, Colorectal Neoplasms

NCT03440515 2020-01-07

Management of Imatinib-associated Severe Skin Rash in Patients With Gastrointestinal Stromal Tumor

Phase 2 Completed

29 enrolled

GastrointestinalSarcoma

Exanthema, Gastrointestinal Stromal Tumors

NCT01136005 2017-11-13

BeCet

Phase 3 Completed

160 enrolled

Exanthema, Neoplasms

NCT01931150 2017-01-13

Study of Prophylactic Topical Dapsone 5% Gel Versus Moisturizer for Cetuximab-induced Papulopustular (Acneiform) Rash in Patients With mCRC or HNSCC Without Previous or Concurrent RT

Phase 3 Completed

11 enrolled 7 charts

Gastrointestinal

Exanthema, Colorectal Neoplasms

NCT00803842 2015-02-26

Erlotinib Pharmacokinetics During Doxycycline Treatment for Erlotinib-induced Rash

Phase NA Withdrawn

Thoracic

Carcinoma, Non-Small-Cell Lung, Exanthema

NCT01315990 2013-12-18

DERMATUX

Phase 4 Unknown

165 enrolled

Gastrointestinal

Exanthema, Colorectal Neoplasms

NCT01299220 2013-01-16

Study of Acitretin to Treat Skin Rash Caused by Erlotinib (a Chemotherapy Drug)

Phase 4 Withdrawn

Exanthema, Neoplasms

NCT00158041 2005-09-12

Subcutaneous Amifostine Safety Study

Phase 4 Completed

452 enrolled

Head & NeckLymphoidOtherThoracic

Exanthema, Head and Neck Neoplasms, Hypotension, Lung Neoplasms, Lymphoma, Nausea, Mucositis

Clinical Trials

TREATS